Comprehensive Management of Influenza A (H1N1 and H3N2): 2025–2026 Clinical Protocols and Pharmaceutical Solutions
In the current 2025–2026 influenza season, the global healthcare landscape is facing a significant surge in Influenza A activity, primarily driven by the H1N1 and H3N2 subtypes. Of particular concern to clinicians is the emergence of the H3N2 subclade K (J.2.4.1), which has demonstrated notable genetic drift, potentially impacting vaccine…